Skip to main content
Equibles
MRVI logo

MRVI · Maravai Lifesciences Holdings, Inc. · Webcasts, Transcripts & Audio

Track MRVI — free

Use MRVI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MRVI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.50 -0.16 (-2.09%) At close · Oct 1
Russell 2000 member Rebalance outlook locked
Market Cap
$1.97B
Shares
259.67M
Volume · Oct 1 4.34M Avg daily vol (3M) 3.27M

Maravai Lifesciences Holdings, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Maravai Lifesciences Holdings, Inc. (MRVI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼6.6% $191.26M $44.47M '22 Q3 22-11-02 ▼10.4% $204.71M $37.63M '22 Q4 23-02-22 ▼67.7% $79.03M −$67,000 '23 Q1 23-05-08 ▼71.6% $68.91M −$6.54M '23 Q2 23-08-07 ▼65% $66.86M −$6.46M '23 Q3 23-11-07 ▼63.8% $74.14M −$105.96M '23 Q4 24-02-22 ▼18.8% $64.18M −$12.08M '24 Q1 24-05-08 ▲0.7% $69.42M −$9.79M '24 Q2 24-08-07 ▲3.2% $69.03M −$97.07M '24 Q3 24-11-07 ▼23.7% $56.56M −$25.91M '24 Q4 25-02-25 ▼27% $46.85M −$29.95M '25 Q1 25-05-12 ▼31.7% $47.40M −$39.59M '25 Q2 25-08-11 ▼39.7% $41.63M −$25.56M '25 Q3 25-11-06 ▼11.8% $49.87M −$35.68M '25 Q4 26-02-25 ▲40.5% $65.84M −$3.73M '26 Q1 26-05-07 LATEST ▲8.5% $51.44M −$12.42M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Maravai Lifesciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript
Confident tone TriLink mRNA Growth ModTail Adoption Commercial Execution
Revenue
$51.44M
▲ 8.5% YoY
Diluted EPS
$-0.08
Gross margin
40.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-04
Maravai Lifesciences Holdings, Inc. (MRVI) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Maravai Lifesciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
Confident tone TriLink revenue growth Cygnus performance ModTail adoption
Revenue
$65.84M
▲ 40.5% YoY
Diluted EPS
$-0.02
Gross margin
51.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Maravai Lifesciences Holdings, Inc. (MRVI) Q4 2025 Earnings Call Transcript
Confident tone 2026 guidance and outlook Adjusted EBITDA recovery Trilink commercial execution and CleanCap
Revenue
$49.87M*
▼ 11.8% YoY
Gross margin
25.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Maravai Lifesciences Holdings, Inc. (MRVI) Q3 2025 Earnings Call Transcript
Positive tone Nucleic Acid Products / TriLink Recovery Product Innovation and Launches Cost Restructuring and EBITDA Improvement
Revenue
$41.63M
▼ 39.7% YoY
Diluted EPS
$-0.18
Gross margin
13.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Maravai Lifesciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript
Positive tone Nucleic Acid Production (NAP) / mRNA headwinds Path back to profitability CDMO business
Revenue
$47.40M
▼ 31.7% YoY
Diluted EPS
$-0.27
Gross margin
16.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Maravai Lifesciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call Transcript
Positive tone China / BST export exposure Tariffs and supply chain mitigation Guide RNA / oligo and Molecular Assemblies integration
Revenue
$46.85M
▼ 27% YoY
Diluted EPS
$-0.21
Gross margin
16.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Maravai Lifesciences Holdings, Inc. (MRVI) Q4 2024 Earnings Call Transcript
Cautious tone High-volume CleanCap demand and customer inventory New product launches (CleanScribe, etc.) Flanders 2 facility and commercial pipeline
Revenue
$56.56M*
▼ 23.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Maravai Lifesciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript
Cautious tone Nucleic Acid Production (NAP) segment Cost structure and commercial investment Biologics Safety Testing (BST) softness
Revenue
$69.03M
▲ 3.2% YoY
Diluted EPS
$-0.68
Gross margin
46.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Maravai Lifesciences Holdings, Inc. (MRVI) Q2 2024 Earnings Call Transcript
Positive tone Flanders facility ramp-up Margin and pricing dynamics New product introductions (NPI)
Revenue
$69.42M
▲ 0.7% YoY
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Maravai Lifesciences Holdings, Inc. (MRVI) Q1 2024 Earnings Call Transcript
Positive tone Nucleic Acid Production product innovation Return to growth strategy and commercial team Q1 financial results and cash position
Revenue
$64.18M
▼ 18.8% YoY
Diluted EPS
$-0.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-22
Maravai Lifesciences Holdings, Inc. (MRVI) Q4 2023 Earnings Call Transcript
Positive tone CleanCap pipeline expansion Nucleic Acid Production segment Biologics Safety Testing segment
Revenue
$74.14M*
▼ 63.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Maravai Lifesciences Holdings, Inc. (MRVI) Q3 2023 Earnings Call Transcript
Revenue
$66.86M
▼ 65% YoY
Diluted EPS
$-0.05
▼ 114.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Maravai Lifesciences Holdings, Inc. (MRVI) Q2 2023 Earnings Call Transcript
Revenue
$68.91M
▼ 71.6% YoY
Diluted EPS
$-0.05
▼ 109.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Maravai Lifesciences Holdings, Inc. (MRVI) Q1 2023 Earnings Call Transcript
Revenue
$79.03M
▼ 67.7% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Maravai Lifesciences Holdings, Inc. (MRVI) Q4 2022 Earnings Call Transcript
Revenue
$204.71M*
▼ 10.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Maravai Lifesciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript
Revenue
$191.26M
▼ 6.6% YoY
Diluted EPS
$0.34
▼ 22.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Maravai Lifesciences Holdings, Inc. (MRVI) Q2 2022 Earnings Call Transcript
Revenue
$242.73M
▲ 11.5% YoY
Diluted EPS
$0.53
▲ 20.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Maravai Lifesciences Holdings, Inc. (MRVI) Q1 2022 Earnings Call Transcript
Revenue
$244.29M
▲ 64.8% YoY
Diluted EPS
$0.50
▲ 108.3% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Maravai Lifesciences Holdings, Inc. (MRVI) Q4 2021 Earnings Call Transcript
Revenue
$228.44M*
▲ 132.3% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Maravai Lifesciences Holdings, Inc. (MRVI) Q3 2021 Earnings Call Transcript
Revenue
$204.81M
▲ 133.1% YoY
Diluted EPS
$0.44
▲ 266.7% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Maravai Lifesciences Holdings, Inc. (MRVI) Q2 2021 Earnings Call Transcript
Revenue
$217.78M
▲ 364.3% YoY
Diluted EPS
$0.44
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Maravai Lifesciences Holdings, Inc. (MRVI) Q1 2021 Earnings Call Transcript
Revenue
$148.21M
▲ 190.7% YoY
Diluted EPS
$0.24
▲ 166.7% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-02
Maravai Lifesciences Holdings, Inc. (MRVI) Q4 2020 Earnings Call Transcript
Revenue
$98.35M*
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–24 of 24 webcasts
Key facts CIK 1823239 CUSIP 56600D107 13F (30d) 4 filings 4 filers Visit website Investor relations